South and Central America Vitrectomy Devices Market

Market Introduction

Vitrectomy is a surgical procedure employed to treat various problems with the retina and vitreous and remove the vitreous gel from the eye. It is performed during retinal detachment with vitreous hemorrhage. As a result, this smoothens the procedure and prevents any further detachment of the retina. In addition, it is helpful for various repairs, such as the removal of scar tissue. It helps restore the vision loss caused due to vitreous humor bleeding.

Moreover, the significant advancements related to vitreoretinal surgery devices are expected to bolster the market growth during the forecast period. However, complications associated with vitrectomy limit the growth of the South & Central America vitrectomy devices market.

The outbreak of COVID–19 has stringently affected medical services in the South and Central America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. It is anticipated that Argentina will likely impose a second lockdown, which will eventually hamper the healthcare industry in the area. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the second wave of corona infection. Amongst which Brazil has registered the majority of the deaths. It is anticipated that the region will likely force a second lockdown, which will ultimately hamper the healthcare industry in the area.

Market Overview and Dynamics

The South & Central America vitrectomy devices market is expected to reach US$ 121.8 million by 2028 from US$ 87.9 million in 2021. The market is estimated to grow at a CAGR of 4.8% from 2021–2028. The rising demand for cataract, refractive, and vitrectomy surgeries is expected to increase the sales of vitrectomy devices. Leading market players are increasing their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets are expected to offer potential growth opportunities for key vitrectomy device manufacturers in the years to come. This can be attributed to the large patient population, high prevalence of eye diseases, such as cataracts and other vision impairments, increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward vitrectomy surgeries.

Key Market Segments

In terms of product, the vitrectomy machines segment accounted for the largest share of the South & Central America vitrectomy devices market in 2020. In terms of patient type, the geriatric segment accounted for the largest share of the South & Central America vitrectomy devices market in 2020. In terms of surgery approach, the posterior/pars plana vitrectomy segment accounted for the largest share of the South & Central America vitrectomy devices market in 2020. In terms of application, the diabetic retinopathy segment accounted for the largest share of the South & Central America vitrectomy devices market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the South & Central America vitrectomy devices market in 2020. In terms of distribution channel, the retail sales segment accounted for the largest share of the South & Central America vitrectomy devices market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the vitrectomy devices market in South & Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are D.O.R.C Dutch Ophthalmic Research Center (International)B. V, HOYA Corporation, Danaher (Leica Microsystems AG), Carl Zeiss Meditec, Alcon Inc., Bausch Health Companies Inc., and Topcon Corporation.

Reasons to Buy Report

• To understand the South & Central America vitrectomy devices market landscape and identify market segments that are likely to guarantee a strong return
• To comprehend the ever-changing market landscape and stay ahead in competition
• To efficiently plan merger and acquisition, and partnership deals in the South & Central America vitrectomy devices market by identifying segments with the most promising probable sales
• To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
• To obtain market revenue forecast of the South & Central America vitrectomy devices market based on various segments for the period 2021–2028

SOUTH & CENTRAL AMERICA VITRECTOMY DEVICES MARKET SEGMENTATION

By Product

• Vitrectomy Machines
• Vitrectomy Accessories
• Microscopic Illumination Equipment
• Surgical Instruments
• Others

By Patient Type

•  Geriatric
• Adult
• Pediatrics

By Surgery Approach

•  Posterior/Pars Plana Vitrectomy
• Anterior Vitrectomy

By Application

•  Diabetic Retinopathy
• Retinal Detachment
• Epiretinal Membrane
• Macular Hole
• Others

By End User

•  Hospitals
• Ophthalmology Clinics
• Ambulatory Surgery Centers (ASCs)

By Distribution Channel

• Retail Sales
• Direct Tenders
• Third Party Distributors Retinal

By Country

• South & Central America
• Brazil
• Argentina
• Rest of South & Central America

Companies Mentioned

• D.O.R.C Dutch Ophthalmic Research Center (International)B. V     
• HOYA Corporation          
• Danaher (Leica Microsystems AG)             
• Carl Zeiss Meditec           
• Alcon Inc.               
• Bausch Health Companies Inc.        
• Topcon Corporation       

South and Central America Vitrectomy Devices Market Strategic Insights

South and Central America Vitrectomy Devices Market Report Highlights

South and Central America Vitrectomy Devices Market Country and Regional Insights